Events

Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional.

The April 17th office hours will be hosted by Louise Sarup, Ph.D., Associate Director, Business Development and Licensing. Louise manages a portfolio of medical technologies focusing on imaging, platform technologies and algorithms. She is a seasoned professional with years of experience in licensing and commercialization and is eager to answer your questions and provide valuable insights.

Prior to joining the Center for Technology Licensing, Louise was based in Singapore where she was head of business development and licensing for D3 (now EDDC), a drug discovery and development group based at A*STAR. Some of her previous roles include corporate development manager at S*BIO Pte Ltd. (Singapore), an oncology-focused biotech, vice president of business development at Paramount Biosciences (London), where she was responsible for in-licensing drug development assets and director (licensing) at Cytiva, a global life science company. Louise has also worked for leading life science and health care communication agencies and UCL Business, the commercialization company of University College London.

Register here for your 30-minute private session.

Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to get an answer to their intellectual property questions and gain more information about the advancement of their IP filings with a one-on-one meeting.

The Tuesday, April 15, office hours will be hosted virtually by Eric Bryant, M.S., J.D., Intellectual Property Officer, Biomedical Sciences.  

Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution. Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.

To reserve your private, 30-minute Zoom session with Eric, click here and select your preferred time. 

Join our distinguished special panel to explore the critical intersection of medical device innovation and regulatory guidance. The panel will unpack the complex path from scientific discovery to market-ready medical innovation. We'll explore the strategic, technical and regulatory considerations that transform promising research into technologies that can improve patient care.

This session is ideal for anyone interested in medical devices and understanding the journey from idea to real-world healthcare applications.

Our expert panelists will share their practical insights on:

• Navigating FDA approval processes
• Balancing innovation with regulatory compliance
• Strategies for successful device development
• Emerging challenges in medical device development

Whether you're considering a new idea, commercialization, or actively developing medical device solutions, this panel offers valuable perspectives on turning promising research into market-ready medical devices.

Panelists:

• Mark Melkerson, former FDA Deputy Director, Office of Health Technology / CDRH / ODE and current MNM Consulting
• Thomas Roueche, President and CEO, Fesarius Therapeutics
• Jason Spector, M.D., Chief of the Division of Plastic and Reconstructive Surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, Co-Founder of Fesarius Therapeutics

Register now!

As a graduate student, many career options lie in front of you. One potential route is founding a startup based on the innovative research conducted in your lab. Beginning a startup company is complex and challenging. While there are now many programs to assist academics in their startup endeavors, some aspects you learn as you build the venture. Come hear from two successful startup CEOs who founded startups as graduate students. They will discuss their journeys:

• Making the switch from academia to a new venture
• Fundraising
• Building their teams
• Challenges both expected and unforeseen
• The ultimate exits made by their first startups

Dr. Shelley Force Aldred founded her first startup as a graduate student at Stanford University and now is on her third new venture. Dr. Laura Schewel founded her first startup, StreetLight Data, while a graduate student at Berkeley.  

Learn more about both speakers and register here. 

The 2025 Weill Cornell Medicine Biomedical Innovation Conference brings together academic founders with investors, industry representatives, entrepreneurs and ecosystem partners with the expressed goal to connect and collaborate. The conference is a rare opportunity to meet a diverse group of life science inventors and spinout companies across therapeutics, device, digital health and diagnostic sectors. All Weill Cornell Medicine-affiliated inventors are encouraged to participate. In addition, select startup companies from the Upper East Side ecosystem, including Rockefeller University, Memorial Sloan Kettering, and surrounding hospitals, as well as startups where faculty serve as CMOs and Scientific Advisors, are also in attendance.

Over the years, this event has been a proven catalyst for direct investment from early-stage investors, co-development relationships with industry, and introductions to experienced management teams. Please contact Loren Busby at lob4002@med.cornell.edu for more information.

We look forward to welcoming you to the Weill Cornell Medicine campus!

RSVP here. 

Ready to bring your product idea to life? Apply to the Summer 2025 Prototyping Hardware Accelerator. 

The final application deadline is March 28, 2025. 

Over 10 weeks, Rev’s Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

• MedTech Track: Offered in partnership with Cornell Biomedical Engineering and Weill Cornell Medicine, the new MedTech track provides access to specialized prototyping equipment, regulatory resources, and research and medical professionals in the field.  

The accelerator is held in person at Rev: Ithaca Startup Works in Ithaca, New York beginning in late May 2025. The program is free and open to the public.   

Want to learn more? Register to attend an upcoming virtual information session: 

• Thursday, February 27, 2025 from 4:30 - 5:30 PM ET 
• Tuesday, March 18, 2025 from 6 - 7 PM ET 

Note: Digital platforms, applications, and other software programs are not eligible unless paired with a physical product that you intend to develop in our program.  

Rev encourages you to share this information with interested hardware entrepreneurs and your extended networks. Questions about the program can be directed to rev@revithaca.com.   

Osage University Partners (OUP) is pleased to invite you to its annual startup financing trends webinar.

Join Nabil Ullah and Justin Robeny of OUP’s investment team for a discussion on startup financing trends to review the state of the venture funding landscape.

The webinar will cover current market behaviors across the entire startup ecosystem with a specific emphasis on university spinouts. Justin Robeny will outline trends in the life sciences, including biopharma, research tools, diagnostics and medical devices while Nabil Ullah will review the tech and physical sciences, ranging from software to climate tech.

OUP leverages public sources and its own proprietary database of active university spinouts from its partner institutions to provide unique insights and perspectives for 2025 and beyond.

Register here. 

Enterprise Innovation will be hosting a virtual panel focused on the critical aspects of preclinical drug discovery. The panel will feature experienced biotech investors and industry scientists who will provide guidance on the key steps involved in de-risking a novel drug development idea. This program will be useful to Weill Cornell researchers interested in starting a drug discovery project or optimizing existing compounds for the purpose of attracting commercial partnership or investment interest. 

What you’ll learn:

• Criteria for choosing therapeutic target, drug modality and clinical indication with significant unmet need
• Key stages of drug discovery, including high throughput screening, hit finding strategies and choosing a lead compound
• Understanding the differences between small molecule and biologics discovery campaigns
• Assessing the target product profile (TPP), including safety liabilities, efficacy benchmarks, dose finding, pharmacokinetics and appropriate “therapeutic benchmarks”

Register here. 

*This panel is a kickoff event for the 2025 Biomedical Innovation Conference. 

Are you interested in exploring a career in pharma R&D? This is a rare opportunity to see how your education can transfer to the day-to-day work of patient-centric drug development. Experience this unique opportunity to learn from our scientists and meet them in person.

This seminar runs from March to May 2025. It will be held virtually and in person May 2nd. 

Scan the QR code on the flyer below or visit here to fill out the registration form. 

For more information, please contact: Gaylene Anderson, U.S. Director, Strategic Research Relationships at gaylene.anderson@boehringer-ingelheim.com. 

boehringer_drug_discovery_course.pdf

Applications are open for the Summer 2025 Prototyping Hardware Accelerator at Rev: Ithaca Startup Works! 

Over 10 weeks, Rev’s in-person Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype. 

Want to learn more? Register to attend an upcoming virtual information session. Questions? Contact rev@revithaca.com.